Drug Topics

OCTOBER 5, 2023

It’s crucial to be openminded about these approaches, and to convey accurate information to patients in a nonjudgmental manner.

530

530

STAT

OCTOBER 5, 2023

The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline. While a representative of vaccine manufacturers warned it may not be possible to remove the influenza B/Yamagata component from the flu vaccines that will be made for the Northern

Vaccines 145

Vaccines FDA 145

Drug Topics

OCTOBER 5, 2023

Collaboration among faculty, students, national associations, and community pharmacy leaders is crucial as pharmacy practice continues to transform.

Community Pharmacies 500

Community Pharmacies 500

Pharmacy Times

OCTOBER 5, 2023

Study findings indicated that many health care facilities are recovering from the COVID-19 pandemic and shortage of staff, which has caused door-to-balloon times to lag.

143

143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

OCTOBER 5, 2023

Fezolinetant (Veozah) is approved for the treatment of moderate to severe vasomotor symptoms (ie, hot flashes and night sweats) related to menopause.

247

247

Pharmacy Times

OCTOBER 5, 2023

Investigators found that the adjusted mean change in A1C was –0.62% for dapagliflozin compared to 0.41% for a placebo in patients with type 2 diabetes.

139

139

Pharmacy Times

OCTOBER 5, 2023

Study shows a a significant burden of hospitalizations associated with respiratory syncytial virus during the 2021-2022 season compared with the prepandemic period.

Hospitals 139

Hospitals 139

STAT

OCTOBER 5, 2023

Anyone picking up a prescription from their pharmacy is used to the reams of paper that typically accompany it: information on safety, storing, and how to use the drug. What if that information also included your medicine’s carbon footprint? Some scientists are trying to calculate those footprints, as part of a growing effort to understand biotech and pharmaceutical companies’ contributions to climate change.

Pharmaceutical Companies 137

Pharmaceutical Companies Pharmaceutical Companies 137

Pharmacy Times

OCTOBER 5, 2023

Naveen Mansukhani, BPharm, National Operations Director for Cardinal Health Retail Pharmacy Services, discussed how he is celebrating American Pharmacists Month.

132

132

STAT

OCTOBER 5, 2023

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart. Three years later, Histogen no longer develops therapies.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

OCTOBER 5, 2023

Tune in to this episode of Public Health Matters to gain a profound understanding of health equity, the enduring racial disparities in health care, and the essential work of supporting individuals as they reenter society.

132

132

Pharmacy Is Right For Me

OCTOBER 5, 2023

The CVS Health Minority Scholarship for Pharmacy Students was awarded to five outstanding underrepresented minority (URM) student pharmacists who are currently pursuing their PharmD degree. Selected awardees demonstrated outstanding leadership, academic success, and a commitment to advancing the profession of pharmacy and patient care. This scholarship will support them in their goal of becoming pharmacists by reducing financial barriers.

Patient Care 130

Patient Care 130

Pharmacy Times

OCTOBER 5, 2023

Patients often turn to dietary supplements for the management of osteoarthritis, one of which is turmeric.

132

132

STAT

OCTOBER 5, 2023

STAT’s Mohana Ravindranath and Annalisa Merelli will be at HLTH in Las Vegas and will be writing a daily email dispatch from the meeting. Sign up here to get it. Health leaders are jetting to Las Vegas this weekend for a meeting they say is crucial for clinching new deals and cooking up new startups — all while mingling with TV personalities, social media influencers, musicians and ten thousand other health care professionals on the industry’s flashiest exhibitor floor.

127

127

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

OCTOBER 5, 2023

Roche app relieves diabetes distress in clinical trial Phil.

125

125

STAT

OCTOBER 5, 2023

The shortage of cancer drugs is not going away, but it may be easing slightly, a new national survey suggests. Based on questions posed to 29 of its 33 member hospitals, the National Comprehensive Cancer Network said Thursday that 86% of those cancer centers are experiencing a shortage of at least one type of generic chemotherapy drug, down from 90% in May.

Chemotherapy 126

Chemotherapy Hospitals 126

Pharmaceutical Commerce

OCTOBER 5, 2023

In an interview at LogiPharma USA 2023 with Pharma Commerce Editor Nicholas Saraceno, Tracy Nasarenko, Sr. Director of Community Engagement for Pharmaceuticals, GS1 US highlights her “DSCSA—Final Checks to Have Before Deadlines.

124

124

STAT

OCTOBER 5, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, all. Damian here with a rare look at a biotech in collapse, Moderna’s ambitious future in vaccines, and what looks like a massive missed opportunity.

Vaccines 124

Vaccines 124

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

OCTOBER 5, 2023

Little progress has been made in developing treatments that can help to stop Ewing sarcomas from spreading or coming back.

123

123

STAT

OCTOBER 5, 2023

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday. Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS , which is one of the most common genetic mutations in cancer.

FDA 123

FDA 123

Fierce Healthcare

OCTOBER 5, 2023

Healthcare providers have promised that timely, convenient and affordable care built with the patient in mind is just around the corner. | Retailers are placing big bets on their customers’ willingness to trust them with their healthcare needs. Consumer trust in our healthcare system is at an all-time low, largely due to stubborn barriers like the lack of price transparency and equal access to care.

120

120

pharmaphorum

OCTOBER 5, 2023

UK Biobank study “will shape drug discovery” Phil.

118

118

STAT

OCTOBER 5, 2023

LONDON — The Japanese firm Kyowa Kirin is acquiring gene therapy maker Orchard Therapeutics in a $400 million deal, the companies said Thursday. Kyowa Kirin is paying $16 per share — a nearly 100% premium on Orchard’s Wednesday closing price — in cash, amounting to roughly $390 million. Orchard shareholders stand to earn another $90 million if Orchard’s gene therapy, Libmeldy, wins U.S. approval.

117

117

pharmaphorum

OCTOBER 5, 2023

How AI and omnichannel are transforming pharma marketing Mike.

116

116

STAT

OCTOBER 5, 2023

It should be obvious that medical school and clinical experience, in themselves, can’t fully prepare someone for the C-suite, any more than an MBA and corporate leadership experience equip someone to be a doctor. But all too many health care organizations promote their best physicians to chief medical officer (CMO) on the assumption that they can pick up the new skills they need on the fly.

Medical Schools 117

Medical Schools Hospitals 117

Fierce Healthcare

OCTOBER 5, 2023

UnitedHealthcare's Surest, which axes deductibles and provides upfront pricing data to members, is the fastest growing product among its commercial plan lineup. | UnitedHealthcare's Surest, which axes deductibles and provides upfront pricing data to members, is the fastest growing product among its commercial plan lineup. And a new analysis offers a look as to why.

113

113

Pharmaceutical Commerce

OCTOBER 5, 2023

Panel discusses how digital transformation can best impact supply chains.

111

111

Fierce Healthcare

OCTOBER 5, 2023

Some 42% of Native Americans have visited the ER because of a Type 2 diabetes complication, a new survey showed. | Some 42% of Native Americans have visited the ER because of a Type 2 diabetes complication, according to the survey.

113

113

Hospital Pharmacy Europe

OCTOBER 5, 2023

The first pilot cohort of pharmacists have completed the Royal Pharmaceutical Society (RPS) advanced e-portfolio pathway, which was launched in March 2023 to recognise and quality assure advanced pharmacist practice in England. The seven pharmacists are now eligible for the NHS England (NHSE) Centre of Advancing Practice’s ‘Advanced’ digital badge, and those who are members of the RPS may now use the membership affix MRPharmS (Advanced).

Hospitals 111

Hospitals 111

pharmaphorum

OCTOBER 5, 2023

Benefits of including QR codes on medication packaging Mike.

Packaging 110

Packaging 110

Fierce Healthcare

OCTOBER 5, 2023

Froedtert Health is buying out Ascension’s 50% stake in a Wisconsin health plan jointly run by the nonprofit health systems, the former announced this week. | The deal, which is pending review, would give Froedtert Health full ownership of a commercial and Medicare payer with 117,000 members.

109

109

STAT

OCTOBER 5, 2023

Rise and shine, another busy day is on the way. We can tell because the official mascots got an early start chasing down cats, squirrels, and other creatures darting about the Pharmalot campus. And then there is the noisy clamor of drills and saws and the like up and down the street. As for us, we are firing up the trusty coffee kettle to brew another cup of stimulation.

Packaging 109

Packaging Dosage Hospitals 109

Drug Store News

OCTOBER 5, 2023

The retailer’s common stock will continue to be listed and traded on the NYSE during the 'cure periods,' subject to the company’s compliance with other continued listing requirements.

106

106